L. Dodion, JM. de Suray; M. Deblecker; A. Georges, [Pharmacokinetic characteristics and biodegradation of aprindin in man]., in Therapie, vol.29, n.2, pp.221-32, PMID 4849380.
PJ. Murphy, Metabolic pathways of aprindine., in Acta Cardiol, Suppl 18, 1974, pp.131-42, PMID 4213697.
KE. Wirth, G. Breithardt; L. Michaelis, [Detection of aprindine and its metabolites in plasma and urine]., in Herz, vol.8, n.5, Ott 1983, pp.302-8, PMID 6642401.
A. Georges, Y. Gerin; A. Ghys; J. Denef; H. Heuker; N. Labar, Toxicological study of aprindine., in Arzneimittelforschung, vol.23, n.4, Apr 1973, pp.519-31, PMID 4740230.
DP. Zipes, WE. Gaum; PR. Foster; KM. Rosen; D. Wu; F. Amat-Y-Leon; RJ. Noble, Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome., in Am J Cardiol, vol.40, n.4, Ott 1977, pp.586-96, PMID 910722.
JP. Van Durme, MG. Bogaert; MT. Rosseel, Comparison of the therapeutic effectiveness of aprindine, procainamide and quinidine in chronic ventricular dysrhythmias., in Br J Clin Pharmacol, vol.1, n.6, Dic 1974, pp.461-6, PMID 22454931.
W. Southworth, KJ. Friday; R. Ruffy, Possible amiodarone-aprindine interaction., in Am Heart J, vol.104, 2 Pt 1, Ago 1982, p.323, PMID 7201738.